Speakers

Dorothea Ledergerber

Chief Technical Officer • Tigen Pharma

Dorothea is a pharmacist with more than 20 years of experience in research, development, manufacturing and supply of pharmaceutical products. She received her PhD from the University of the Saarland, Saarbrücken, Germany.

While with Novartis, she was leading manufacturing sites in Switzerland, Germany and
Ireland. A highlight in her career was the build-up and operational launch of the first
commercial Cell & Gene manufacturing facility for Novartis in Europe.

In 2020, Dorothea moved on to Tigen Pharma, a Swiss biotech company in the field of cell
therapies to cure cancer. Tigen is a disruptive catalyst, combining a unique culture with a
multidisciplinary set of clinical and technical capabilities and a long-term perspective to the
benefit of patients and society.

Dorothea is a firm believer in cross-cultural and -functional teams to go beyond the beaten
industry track.

Also speaking

Andrea Zobel

Senior Director, Personalized Supply Chain • World Courier Management Ltd

John Campbell

Director, Tissues Cells & Advanced Therapeutics • Scottish National Blood Transfusion Service

Stephan Grupp

Medical Director Cell & Gene Therapy Lab • Children’s Hospital of Philadelphia

Event Info

Image

Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.
Image

2022 Post-Event Report

Download the post-event report for Advanced Therapies Europe 2022.